Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2013

01-09-2013

Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists

Authors: Winson Y. Cheung, Noreen Aziz, Anne-Michelle Noone, Julia H. Rowland, Arnold L. Potosky, John Z. Ayanian, Katherine S. Virgo, Patricia A. Ganz, Michael Stefanek, Craig C. Earle

Published in: Journal of Cancer Survivorship | Issue 3/2013

Login to get access

Abstract

Purpose

New strategies for delivering cancer follow-up care are needed. We surveyed primary care providers (PCPs) and oncologists to assess how physician attitudes toward and self-efficacy with cancer follow-up affect preferences for different cancer survivorship models.

Methods

The survey of physician attitudes regarding the care of cancer survivors was mailed to a randomly selected national sample of PCPs and oncologists to evaluate their perspectives regarding physician roles, knowledge about survivorship care processes, and views on cancer surveillance. Multinomial logistic regression models were constructed to examine how physician attitudes towards, and self-efficacy with, their own skills affected preferences for different cancer survivorship care models.

Results

Of 3,434 physicians identified, a total of 2,026 participants provided eligible responses: 938 PCPs and 1,088 oncologists. Most PCPs (51 %) supported a PCP/shared care model; whereas, the majority of specialists (59 %) strongly endorsed an oncologist-based model (p < 0.001). Less than a quarter of PCPs and oncologists preferred specialized survivor clinics. A significant proportion of oncologists (87 %) did not feel that PCPs should take on the primary role of cancer follow-up. Most PCPs believed that they were better able to perform breast and colorectal cancer follow-up (57 %), detect recurrent cancers (74 %), and offer psychosocial support (50 %), but only a minority (32 %) was willing to assume primary responsibility. PCPs already involved with cancer surveillance (43 %) were more likely to prefer a PCP/shared care than oncologist-based survivorship model (OR, 2.08; 95 % CI, 1.34–3.23).

Conclusions and Implications for Cancer Survivors

PCPs and oncologists have different preferences for models of cancer survivorship care. Prior involvement with cancer surveillance was one of the strongest predictors of PCPs’ willingness to assume this responsibility.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893–907.PubMedCrossRef Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893–907.PubMedCrossRef
2.
3.
go back to reference Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol. 2010;28:4649–57.PubMedCrossRef Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol. 2010;28:4649–57.PubMedCrossRef
4.
go back to reference Hawkes AL, Lynch BM, Owen N, Aitken JF (2011) Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer 47:267–276 Hawkes AL, Lynch BM, Owen N, Aitken JF (2011) Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivors. Eur J Cancer 47:267–276
6.
go back to reference Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;24:5112–6.PubMedCrossRef Earle CC. Failing to plan is planning to fail: improving the quality of care with survivorship care plans. J Clin Oncol. 2006;24:5112–6.PubMedCrossRef
7.
go back to reference Grunfeld E. Looking beyond survival: how are we looking at survivorship? J Clin Oncol. 2006;24:5166–9.PubMedCrossRef Grunfeld E. Looking beyond survival: how are we looking at survivorship? J Clin Oncol. 2006;24:5166–9.PubMedCrossRef
8.
go back to reference Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Committee on Cancer Survivorship, Improving Care and Quality of Life, National Cancer Policy Board, Institute of Medicine, and National Research Council. Washington, DC: National Academies Press; 2006. Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Committee on Cancer Survivorship, Improving Care and Quality of Life, National Cancer Policy Board, Institute of Medicine, and National Research Council. Washington, DC: National Academies Press; 2006.
9.
10.
go back to reference Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005.PubMedCrossRef Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005.PubMedCrossRef
11.
go back to reference Nekhlyudov L, Latosinsky S. The interface of primary and oncology specialty care: from symptoms to diagnosis. J Natl Cancer Inst Monogr. 2010;2010:11–7.PubMedCrossRef Nekhlyudov L, Latosinsky S. The interface of primary and oncology specialty care: from symptoms to diagnosis. J Natl Cancer Inst Monogr. 2010;2010:11–7.PubMedCrossRef
12.
go back to reference Sussman J, Baldwin LM. The interface of primary and oncology specialty care: from diagnosis through primary treatment. J Natl Cancer Inst Monogr. 2010;2010:18–24.PubMedCrossRef Sussman J, Baldwin LM. The interface of primary and oncology specialty care: from diagnosis through primary treatment. J Natl Cancer Inst Monogr. 2010;2010:18–24.PubMedCrossRef
13.
go back to reference Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848–55.PubMedCrossRef Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848–55.PubMedCrossRef
14.
go back to reference Potosky AL, Han PK, Rowland J, Klabunde CN, Smith T, Aziz N, et al. Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26:1403–10.PubMedCrossRef Potosky AL, Han PK, Rowland J, Klabunde CN, Smith T, Aziz N, et al. Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26:1403–10.PubMedCrossRef
16.
go back to reference Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol. 2011;29:1280–9.PubMedCrossRef Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol. 2011;29:1280–9.PubMedCrossRef
17.
go back to reference Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol. 2008;26:1073–9.PubMedCrossRef Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol. 2008;26:1073–9.PubMedCrossRef
18.
go back to reference Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med. 2008;23:254–9.PubMedCrossRef Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med. 2008;23:254–9.PubMedCrossRef
19.
go back to reference Snyder CF, Frick KD, Kantsiper ME, Peairs KS, Herbert RJ, Blackford AL, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27:1054–61.PubMedCrossRef Snyder CF, Frick KD, Kantsiper ME, Peairs KS, Herbert RJ, Blackford AL, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27:1054–61.PubMedCrossRef
20.
go back to reference Snyder CF, Frick KD, Peairs KS, Kantsiper ME, Herbert RJ, Blackford AL, et al. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med. 2009;24:469–74.PubMedCrossRef Snyder CF, Frick KD, Peairs KS, Kantsiper ME, Herbert RJ, Blackford AL, et al. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med. 2009;24:469–74.PubMedCrossRef
21.
go back to reference Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol. 2009;27:2489–95.PubMedCrossRef Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol. 2009;27:2489–95.PubMedCrossRef
22.
go back to reference Cheung WY, Neville BA, Earle CC. Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. J Clin Oncol. 2010;28:2577–83.PubMedCrossRef Cheung WY, Neville BA, Earle CC. Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. J Clin Oncol. 2010;28:2577–83.PubMedCrossRef
23.
go back to reference Jacobs LA, Palmer SC, Schwartz LA, DeMichele A, Mao JJ, Carver J, et al. Adult cancer survivorship: evolution, research, and planning care. CA Cancer J Clin. 2009;59:391–410.PubMedCrossRef Jacobs LA, Palmer SC, Schwartz LA, DeMichele A, Mao JJ, Carver J, et al. Adult cancer survivorship: evolution, research, and planning care. CA Cancer J Clin. 2009;59:391–410.PubMedCrossRef
24.
go back to reference Houlihan NG. Transitioning to cancer survivorship: plans of care. Oncology (Williston Park). 2009;23:42–8. Houlihan NG. Transitioning to cancer survivorship: plans of care. Oncology (Williston Park). 2009;23:42–8.
25.
go back to reference Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs. 2008;24:208–17.PubMedCrossRef Ganz PA, Casillas J, Hahn EE. Ensuring quality care for cancer survivors: implementing the survivorship care plan. Semin Oncol Nurs. 2008;24:208–17.PubMedCrossRef
26.
go back to reference Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians' views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27:3338–45.PubMedCrossRef Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians' views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27:3338–45.PubMedCrossRef
27.
go back to reference Watson EK, Sugden EM, Rose PW. Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey. J Cancer Surviv. 2010;4:159–66.PubMedCrossRef Watson EK, Sugden EM, Rose PW. Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey. J Cancer Surviv. 2010;4:159–66.PubMedCrossRef
28.
go back to reference Warren JL, Mariotto AB, Meekins A, Topor M, Brown ML. Current and future utilization of services from medical oncologists. J Clin Oncol. 2008;26:3242–7.PubMedCrossRef Warren JL, Mariotto AB, Meekins A, Topor M, Brown ML. Current and future utilization of services from medical oncologists. J Clin Oncol. 2008;26:3242–7.PubMedCrossRef
29.
go back to reference Debono D. Coping with the oncology workforce shortage: transitioning oncology follow-up care to primary care providers. J Oncol Pract. 2010;6:203–5.PubMedCrossRef Debono D. Coping with the oncology workforce shortage: transitioning oncology follow-up care to primary care providers. J Oncol Pract. 2010;6:203–5.PubMedCrossRef
30.
go back to reference Frew G, Smith A, Zutshi B, Young N, Aggarwal A, Jones P, et al. Results of a quantitative survey to explore both perceptions of the purposes of follow-up and preferences for methods of follow-up delivery among service users, primary care practitioners and specialist clinicians after cancer treatment. Clin Oncol (R Coll Radiol). 2010;22:874–84.CrossRef Frew G, Smith A, Zutshi B, Young N, Aggarwal A, Jones P, et al. Results of a quantitative survey to explore both perceptions of the purposes of follow-up and preferences for methods of follow-up delivery among service users, primary care practitioners and specialist clinicians after cancer treatment. Clin Oncol (R Coll Radiol). 2010;22:874–84.CrossRef
31.
go back to reference Earle CC, Chretien Y, Morris C, Ayanian JZ, Keating NL, Polgreen LA, et al. Employment among survivors of lung cancer and colorectal cancer. J Clin Oncol. 2010;28:1700–5.PubMedCrossRef Earle CC, Chretien Y, Morris C, Ayanian JZ, Keating NL, Polgreen LA, et al. Employment among survivors of lung cancer and colorectal cancer. J Clin Oncol. 2010;28:1700–5.PubMedCrossRef
32.
go back to reference Casillas J, Castellino SM, Hudson MM, Mertens AC, Lima IS, Liu Q, et al. Impact of insurance type on survivor-focused and general preventive health care utilization in adult survivors of childhood cancer: the Childhood Cancer Survivor Study (CCSS). Cancer. 2011;117:1966–75.PubMedCrossRef Casillas J, Castellino SM, Hudson MM, Mertens AC, Lima IS, Liu Q, et al. Impact of insurance type on survivor-focused and general preventive health care utilization in adult survivors of childhood cancer: the Childhood Cancer Survivor Study (CCSS). Cancer. 2011;117:1966–75.PubMedCrossRef
33.
go back to reference Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer. 2011;117:2779–90.PubMedCrossRef Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer. 2011;117:2779–90.PubMedCrossRef
34.
go back to reference Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24 Suppl 2:S459–66.PubMedCrossRef Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24 Suppl 2:S459–66.PubMedCrossRef
Metadata
Title
Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists
Authors
Winson Y. Cheung
Noreen Aziz
Anne-Michelle Noone
Julia H. Rowland
Arnold L. Potosky
John Z. Ayanian
Katherine S. Virgo
Patricia A. Ganz
Michael Stefanek
Craig C. Earle
Publication date
01-09-2013
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-013-0281-y

Other articles of this Issue 3/2013

Journal of Cancer Survivorship 3/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine